Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Wikipedia
Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Wikipedia
Jeff''s #CancerBreakthrough was when he finally regained enough strength to play with his kids. This inspiring piece by @woes shows what this moment was like for Jeff.
Oct 30 at 4:26 PM
Based on a survey, only 1 in 3 women are knowledgeable about #breastcancer subtypes, which can directly impact treatment options. #BreastCancerAwareness
Oct 23 at 8:05 PM
""I am optimistic about my journey with HER2-positive metastatic breast cancer. At first, I didn''t realize how serious it was and that there isn''t a cure, but with the help of my oncologist I came to understand the specifics of my diagnosis, making me feel more confident in my treatment."" Ramona, age 56, talked to us about how knowledge equals power
Oct 15 at 6:09 PM
When I was diagnosed with HER2-positive metastatic breast cancer, I focused on the good things in my life, like my passion for horses. My oncologist helped me understand my specific type of breast cancer and I was empowered to match my aggressive disease with an aggressive treatment regimen. - Vicki, age 58, living with HER2-positive breast cancer
Oct 30, 7:57 PM
Jeff''s #CancerBreakthrough was when he finally regained enough strength to play with his kids. This inspiring piece by @woes shows what this moment was like for Jeff.
Oct 30, 4:26 PM
Based on a survey, only 1 in 3 women are knowledgeable about #breastcancer subtypes, which can directly impact treatment options. #BreastCancerAwareness
Oct 23, 8:05 PM
""I am optimistic about my journey with HER2-positive metastatic breast cancer. At first, I didn''t realize how serious it was and that there isn''t a cure, but with the help of my oncologist I came to understand the specifics of my diagnosis, making me feel more confident in my treatment."" Ramona, age 56, talked to us about how knowledge equals power
Oct 15, 6:09 PM
When I was diagnosed with HER2-positive metastatic breast cancer, I focused on the good things in my life, like my passion for horses. My oncologist helped me understand my specific type of breast cancer and I was empowered to match my aggressive disease with an aggressive treatment regimen. - Vicki, age 58, living with HER2-positive breast cancer
She/he is expected to manage a broadly-functional team that will facilitate the design, execution, and validation of cell line engineering projects initiated by researchers across the company.
This position will be within the newly-established Cell Engineering Lab, wherein she/he will facilitate the design, execution, and validation of cell line engineering projects initiated by researchers across the company.
Collaborates with relevant teams and other groups to measure and monitor study progress against objectives and plans, including any variances, and proactively communicate any issues, challenges and potential strategies for resolution.
Create strategic roadmaps for organizations to follow to recognize defined strategic goals and objectives and implement associated technology solutions; present strategic recommendations to senior leaders from Business and IT.
The Patent Counsel will help build the company`s small molecule global intellectual property portfolio through strategic planning and execution of patent preparation and prosecution.
Negotiates fees and approve payments of invoices from US Customs, government agencies, and brokers; assists US personnel in completing applications to obtain required import/export permits, i.e. Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), Center for Disease Control (CDC), etc.
In this job you would support small molecule project teams using biophysics, with a focus on SPR, for hit identification, validation, progression, and mechanistic studies.
Support the design of drug product processingequipment for the manufacture of RNA-lipoplex nanoparticles and selection ofdrug product filling equipment for the commercial process.
Collaborates with a variety of internal and external partners and stakeholders, such as clinical investigators, clinicians, scientists and key opinion leaders (KOLs), as well as multidisciplinary internal groups, including other groups in PD, research, business development, commercial operations, legal, etc.
This Assistant/Associate Medical Director will be leading a development team that is studying a novel cancer immunotherapy target as a single-agent and in combination with other immunotherapy agents in multiple solid tumors and hematological malignancies.
Representing the assigned molecules/products, franchise(s) and overall therapeutic area(s) to the highest ethical andprofessional standards and in accordance with guidelines, direction and key marketing strategies.
The individual will focus on developing, validating and executing various immunochemical, biochemical and cell-based assays to evaluate protein therapeutics from both in vitro and in vivo studies to support therapeutic antibody characterization, quantitation of large molecule drug concentration, pharmacodynamics biomarker measurements, and potency evaluation in the context of multidisciplinary project teams.
The successful candidate will apply knowledge of modern software technologies to complex informatics and scientific problems in a dynamic research environment.
Development and execution of resourcing and staffing strategies to ensure delivery of activities and scopes of work from various internal groups and external consultants and/or contractors.
The Systems Administrator will be responsible for development and support of IT infrastructure, vendor hardware, and vendor software associated with mission-critical GxP and non-GxP automation systems, including the Building Automation Systems (BAS) for South San Francisco and Dixon, Facilities Data Historian (centralized data/alarm system) (FDH), and Vendor Specific systems that integrate with the BAS and FDH.
Developing the medical vision and strategy for the respective disease areas (AML/MDS and MM); overseeing clinical evidence generation for the assigned portfolio to ensure all activities are completed on time, to high standards and within budget.
Set the strategy and engineering the automation of activities for orchestration, configuration, construction and provisioning of linux HPC systems and environments for multiple variants of linux (RHEL/Centos, Debian/Ubuntu, SUSE) at the machine and (base) container level.
Working closely with other members of the RSI team to ensure that Cloud implementations work well across RSI services (unix, container, HPC) and integrate with other core services (network, I&AM, tiered storage).
Responsible for engineering and maintaining the API interfaces for the data life cycle management and tiering RSI service including the store, retrieve, index, search and archive capabilities (e.g. iRODS, samverna, mediaflux, etc.).
Identify and communicate to partners the key accomplishments and Work Plan progress throughout the year, including compliance committee discussions and decisions and key policy/training initiatives.
Along with the global publication team, drive and implement publication strategy that facilitates knowledge acquisition and dissemination of key information that informs the appropriate utilization of molecules within the oncology portfolio.
Working with counterparts in [privacy] to ensure that international and local discovery practices comport with legal and business requirement and policy positions with respect to data transfer and storage, including GDPR considerations.
Reviewing and approving (if needed) clinical protocols to ensure medical appropriateness of safety relevant sections such as inclusion/exclusion criteria, safety monitoring and management, and schedule of assessments.
Writes clinical science sections of HA meeting packages and assists in the development and review of other clinical documentation required for regulatory submissions and other regulatory processes.
Annual Report 
